buchspektrum Internet-Buchhandlung

Neuerscheinungen 2016

Stand: 2020-02-01
Schnellsuche
ISBN/Stichwort/Autor
Herderstraße 10
10625 Berlin
Tel.: 030 315 714 16
Fax 030 315 714 14
info@buchspektrum.de

Oliver Gassmann, Markus Hinder, Alexander Schuhmacher (Beteiligte)

Value Creation in the Pharmaceutical Industry


The Critical Path to Innovation
Herausgegeben von Schuhmacher, Alexander; Hinder, Markus; Gassmann, Oliver
2016. 508 p. w. 150 figs. 25 cm
Verlag/Jahr: WILEY-VCH 2016
ISBN: 3-527-33913-2 (3527339132)
Neue ISBN: 978-3-527-33913-6 (9783527339136)

Preis und Lieferzeit: Bitte klicken


Dieses Praktikerbuch ist ein Muss für Berufseinsteiger und Master-Studenten der Betriebswirtschaft, die sich auf eine berufliche Tätigkeit in der Forschung & Entwicklung bei Pharmaunternehmen und Firmen im Bereich Biotechnologie vorbereiten. Die Herausgeber und Autoren verfügen über weitreichende Branchenerfahrung und Erfahrung an einigen der renommiertesten europäischen Wirtschaftshochschulen.
This practical guide for advanced students and decision-makers in the pharma and biotech industry presents key success factors in R&D along with value creators in pharmaceutical innovation.
A team of editors and authors with extensive experience in academia and industry and at some of the most prestigious business schools in Europe discusses in detail the innovation process in pharma as well as common and new research and innovation strategies. In doing so, they cover collaboration and partnerships, open innovation, biopharmaceuticals, translational medicine, good manufacturing practice, regulatory affairs, and portfolio management. Each chapter covers controversial aspects of recent developments in the pharmaceutical industry, with the aim of stimulating productive debates on the most effective and efficient innovation processes.
A must-have for young professionals and MBA students preparing to enter R&D in pharma or biotech as well as for students on a combined BA/biomedical and natural sciences program.
Introduction to the Book
Global Epidemiological Developments
The Value of Pharmaceutical Innovation: Concepts and Assessment
A Review of the Pharmaceutical R&D Efficiency: Costs, Timelines and Probabilities
Financing Pharmaceutical Innovation
Challenges And Options For Drug Discovery
Translational Medicine - Enabling the Proof of Concepts
Preclinical Safety and Risk Assessment
Developing Commercial Solutions for Therapeutic Proteins
The Evolution of Clinical Development: From Technical Success to Clinical Value Creation
Translational Development
40 years of Innovation in Biopharmaceuticals - Will the Next 40 Years be as Revolutionary?
Vaccines - Where Inertia, Innovation and Revolution Create Value, Simultaneously and Quietly
The Patient Centric Pharma Company: Evolution, Reboot or Revolution?
The Pharmaceutical Industry is Opening its R&D Boundaries
Out-licensing in Pharmaceutical Research and Development
Trends and Innovations in Pharmaceutical R&D Outsourcing
New Innovation Models in Pharmaceutical R&D
The Influence of Leadership Paradigms and Styles on Pharmaceutical Innovation
The Role of Modern Portfolio Management in Pharma Innovation
Patent Management throughout the Innovation Life Cycle
The Pharmaceutical Industry in Search of the Next Wave of Commercially Relevant Innovation